Biogen Acquiring Karyopharm’s Treatment for ALS, Other Neurodegenerative Diseases
Biogen is acquiring Karyopharm Therapeutics’ KPT-350 and other potential treatments for neurodegenerative diseases such as ALS. “As a global innovative leader…
Articles by Alice Melão
Q Therapeutics and REPROCELL Partnering on Stem Cell-based Therapies for ALS
Q Therapeutics of the United States and REPROCELL of Japan are teaming up to develop stem cell-based therapies for central…
ALS Affects More Brain Regions Than Just the Movement Control Area, Study Shows
Scientists have long believed that ALS was confined to one area of the brain, but an Irish study shows it…
Rare Mutations Can Interact With Related Proteins to Promote ALS Progression, Study Shows
Rare genetic mutations that affect functionally related proteins act in a synergistic manner to determine the course of ALS, a…
Muscle Imaging Helps Evaluate Nerve Loss in ALS and Other Motor Diseases, U.K. Study Finds
Analyzing muscles via magnetic resonance imaging (MRI) can help detect small physiological changes that happen when motor neuron diseases like…
Biohaven Initiates BHV-0223’s Pivotal Clinical Trial to Demonstrate Bioequivalence to Rilutek
Biohaven Pharmaceutical has dosed the first amyotrophic lateral sclerosis (ALS) patient with its sublingual formulation of riluzole, BHV-0223, in…
BrainStorm Expands Patent Coverage of NurOwn Therapy for ALS, Parkinson’s
BrainStorm Cell Therapeutics is expanding the patent portfolio that protects its NurOwn technology for the treatment of several…
Measuring Neurofilament Levels Might Improve Diagnosis of Early Symptomatic ALS
Routinely measuring neurofilaments in the blood and spinal fluid of people with amyotrophic lateral sclerosis (ALS) can help identify patients…
FDA Grants Orphan Drug Status to RNS60 for ALS Treatment
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to…
FDA Grants Orphan Drug Status to Amylyx’s AMX0035 for Treatment of ALS
The U.S. Food and Drug Administration (FDA) granted orphan drug designation to AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS), …